Julie Wilhelmy
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Julie Wilhelmy, is a Life Science Research Assistant at the Stanford Genome Technology Center, Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA and a research team member at the ME/CFS Collaborative Research Center at Stanford.[1] Her research interests include experimental genomics and immunology. Projects include: analyzing the gene expression patterns of the severely ill patients; analysis of T Cell receptors and gene expression of single cells in Mark Davis' lab; Metabolic Trap Project with Robert Phair; and energy metabolism of ME/CFS patient immune cells with Layla Cervantes.[2]
[edit | edit source]
- Feb 2019, Red blood cell deformability is diminished in patients with Chronic Fatigue Syndrome[3] - (Full text)
- Apr 2019, A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)[4] - (Full text)
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ "SGTC :: Staff". www-sequence.stanford.edu. Retrieved June 10, 2019.
- ↑ "Meet Julie Wilhelmy, ME/CFS Collaborative Research Center at Stanford Team Member". Open Medicine Foundation. July 25, 2018. Retrieved June 10, 2019.
- ↑ Saha, Amit K.; Schmidt, Brendan R.; Wilhelmy, Julie; Nguyen, Vy; Abugherir, Abed; Do, Justin K.; Nemat-Gorgani, Mohsen; Davis, Ronald W.; Ramasubramanian, Anand K. (February 23, 2019). "Red blood cell deformability is diminished in patients with Chronic Fatigue Syndrome". Clinical Hemorheology and Microcirculation. 71 (1): 113–116. doi:10.3233/CH-180469.
- ↑ Esfandyarpour, R.; Kashi, A.; Nemat-Gorgani, M.; Wilhelmy, J.; Davis, R.W. (May 21, 2019). "A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)". Proceedings of the National Academy of Sciences. 116 (21): 10250–10257. doi:10.1073/pnas.1901274116. ISSN 0027-8424.
